How Long Until Bankruptcy...

Discussion in 'Lexicon Pharmaceuticals' started by anonymous, Jul 26, 2019 at 6:32 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    new technology = less efficiency with incredibly higher dosing, requiring much higher price???

    However, they are damned to spend the money to go ahead with Zynquista. Meanwhile they will try to raise more money from investors (captital increase with fresh shares), probably find a dubious marketing partner for Zynquista in Europe for T1D, then run out of money in 2020/2021 before potential approval for T2D in 2022.

    My prognosis: Lexicon will be dead by Dec 2020/Jan 2021
     

  2. anonymous

    anonymous Guest

    as a former pharma rep and now real estate / stock investor i know all this site is sales people that are so negative.with the amount of cash LXRX got you all can easily pull a refi of debt and fund 3-5 years that buys you time through trials easily and phase 4 marketing to find a partner or market it yourself. if you bring the sales in the stock prices with sky rocket.
     
  3. anonymous

    anonymous Guest

    Nah. That won’t happen. The leadership in this company have no clue what they are doing. That’s why people leave. They won’t be smart enough to NOT fail!
     
  4. anonymous

    anonymous Guest

    Leadership is on it. They will get it done.
     
  5. anonymous

    anonymous Guest

    Refi gets you what? Who wants to be on the bad end of that deal
     
  6. anonymous

    anonymous Guest

    Did this company fold yet?
     
  7. anonymous

    anonymous Guest

    Oh Arthur, Oh Arthur where art thou? Our ship is listing and we need a captain....
     
  8. anonymous

    anonymous Guest

    I am glad leadership took advice from cafepharma as I posted this a year ago, and they did sell Xermelo and got rid of everyone to survive. Now a research company in Ph 2 trials.
     
  9. anonymous

    anonymous Guest

    still a zombie company- starting Ph2. who's going to partner given their history? btw- compound is BMS's work
     
  10. anonymous

    anonymous Guest

    The Coats effect...
     
  11. anonymous

    anonymous Guest

    Wow, you bombed on both
     
  12. anonymous

    anonymous Guest

    Let me guess, you are not advancing to the next step thru the interview process.
     
  13. anonymous

    anonymous Guest

    Look at Xermelo. That tells you everything you need to know about what this shitshow knows about commercialization. You’ve been forewarned.